USA Financial Formulas’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-18
Closed -$2K 398
2018
Q4
$2K Buy
18
+15
+500% +$1.11K ﹤0.01% 298
2018
Q3
$0 Hold
3
﹤0.01% 442
2018
Q2
$0 Hold
3
﹤0.01% 309
2018
Q1
$0 Buy
+3
New +$288 ﹤0.01% 447
2017
Q4
Sell
-24,590
Closed -$3.59M 372
2017
Q3
$3.59M Buy
+24,590
New +$3.35M 0.85% 37
2015
Q2
Sell
-40,210
Closed -$4.63M 312
2015
Q1
$4.63M Buy
+40,210
New +$4.8M 1.51% 15

Other funds holding CELG

USA Financial Formulas's CELG Position: Q1 2019 in Review

USA Financial Formulas sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 18 shares — an estimated $2K sold.

USA Financial Formulas first reported a position in CELG in Q1 2015 and held it in 6 quarters. The position peaked at $4.63M in Q1 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • USA Financial Formulas reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • USA Financial Formulas sold 18 Celgene Corp shares in Q1 2019, an estimated $2K.
  • USA Financial Formulas first reported a position in Celgene Corp in Q1 2015 and held it in 6 quarters.
  • USA Financial Formulas's Celgene Corp position peaked at $4.63M in Q1 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on USA Financial Formulas's 13F filing for Q1 2019, filed 14 May 2019.